More than a decade ago, the Food and Drug Administration warned doctors not to prescribe testosterone merely because an ...

Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...

Learn why the FDA is asking to update testosterone replacement therapy labels after a major review of new evidence.

This article was reviewed by Mike Bohl, MD, MBA, MPH, MS, ALM. When you're looking for solutions to improve your intimate function, it's easy to get overwhelmed by the vast array of treatments ...

Signs and symptoms of low testosterone are often very generalizable and can be due to something else, either in addition to ...

After years of research, we finally understand how GLP-1s impact T on day 1 versus years later.

A combined US Food and Drug Administration (FDA) advisory committee has voted against recommending approval of oral testosterone undecanoate (TU) gel capsules as testosterone-replacement therapy (TRT) ...

WASHINGTON (AP) — Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be ...

Testosterone replacement has long been prescribed for men who suffer from abnormally low levels of the male sex hormone, but overuse can lead to infertility and can even speed the growth of prostate ...

GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.